Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ALM223
/
Almirall
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|||
|||||||
ALM223
/
Almirall
New P1 trial:
To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects
(clinicaltrials.gov) - Sep 1, 2023
P1
, N=84, Recruiting,
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.